Evonik Industries has shown significant growth, with a 25% EBITDA increase and a 42% FCF rise, making it a strong investment. The company's reorganization and focus on renewables position it well for future growth, despite current macroeconomic volatility. My price target for Evonik is €24.5/share, with a "Buy" rating due to its undervaluation and potential for long-term gains.
Evonik Industries AG (OTCPK:EVKIF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Christian Kullmann - Chairman of the Executive Board Maike Schuh - Chief Financial Officer Conference Call Participants Andreas Heine - Stifel Chetan Udeshi - JPMorgan Sebastian Bray - Berenberg Martin Roediger - Kepler Cheuvreux Georgina Iwamoto - Goldman Sachs Christian Kullmann Thanks a lot, and welcome, ladies and gentlemen, to our full-year earnings call. We have four key messages that we want to bring across today.
Evonik's restructuring into growth and efficiency segments, with a focus on premiumization and defensive markets, has shown mixed results amid challenging industrial macro conditions. Despite a stable 3Q24 with improved EBITDA and cost savings, the company's forecasted growth has not fully materialized, leading to a conservative "Buy" rating. The company's high dividend yield, conservative credit rating, and potential for earnings reversal present an attractive investment opportunity, despite current volatility and ownership pressure.
![]() EVKIF In 10 months Estimated | Annual | $1.21 Per Share |
![]() EVKIF 1 month ago Paid | Annual | $1.21 Per Share |
![]() EVKIF 1 month ago | Other | $1.38 Per Share |
![]() EVKIF 6 Jun 2024 Paid | Annual | $1.26 Per Share |
![]() EVKIF 5 Jun 2024 | Other | $1.38 Per Share |
![]() EVKIF 1 Jun 2023 Paid | Annual | $1.38 Per Share |
1 Aug 2025 (In 3 weeks) Date | | 0.42 Cons. EPS | - EPS |
12 May 2025 Date | | - Cons. EPS | - EPS |
5 Mar 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | 0.53 EPS |
1 Aug 2024 Date | | - Cons. EPS | - EPS |
![]() EVKIF In 10 months Estimated | Annual | $1.21 Per Share |
![]() EVKIF 1 month ago Paid | Annual | $1.21 Per Share |
![]() EVKIF 1 month ago | Other | $1.38 Per Share |
![]() EVKIF 6 Jun 2024 Paid | Annual | $1.26 Per Share |
![]() EVKIF 5 Jun 2024 | Other | $1.38 Per Share |
![]() EVKIF 1 Jun 2023 Paid | Annual | $1.38 Per Share |
1 Aug 2025 (In 3 weeks) Date | | 0.42 Cons. EPS | - EPS |
12 May 2025 Date | | - Cons. EPS | - EPS |
5 Mar 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | 0.53 EPS |
1 Aug 2024 Date | | - Cons. EPS | - EPS |
Chemicals - Specialty Industry | Basic Materials Sector | Mr. Christian Kullmann CEO | OTC PINK Exchange | DE000EVNK013 ISIN |
DE Country | 31,585 Employees | 30 May 2025 Last Dividend | - Last Split | - IPO Date |
Evonik Industries AG is a global leader in the production of specialty chemicals, serving a diverse range of markets including Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company structurally organizes its vast product offerings into five key segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. Each segment caters to specific industry needs, ranging from construction and automotive to nutrition, healthcare, and beyond. Evonik's innovative approach is underpinned by a rich history that dates back to 1873, with its headquarters in Essen, Germany. As a subsidiary of RAG-Stiftung, Evonik stands out for its commitment to sustainability, technology-driven solutions, and integrated services that support and advance chemical production worldwide.
This segment provides crucial components for a variety of applications, including polyurethane coatings, paints, and adhesives. Key products include matting agents for paints and coatings, fumed silicas for paints and printing inks, isophorone and epoxy curing agents for coatings and composites, and additives for improving oil lubricants in construction machinery and the automotive sector.
Evonik caters to the animal nutrition industry with essential amino acids such as D-/L-methionine and lysine. In the healthcare sector, it produces pharmaceutical active ingredients, biocompatible and bioresorbable materials for orthopedic applications, and also offers system solutions for the cosmetics and detergent industries.
Under this segment, Evonik delivers inorganic materials such as fumed and precipitated silicas and silanes, peroxides for the paper and textile industries, specialty catalysts, polymers like polymide 12, and various alkoxide-based products. These smart materials are designed for high-efficiency and sustainability in industrial applications.
This segment's offerings include C4 derivatives like butadiene and MTBE, superabsorbents for hygiene products, and other key chemicals for the automotive industry. The focus here is on enhancing performance and efficiency in consumer goods and industrial processes.
Providing vital support services, Evonik helps optimize energy management, maintenance, process safety, and overall operational excellence in chemical production. This includes digital solutions, integrated plant support, logistics, and strategic site development services tailored to the intricate needs of the chemical industry.